News

"Answers Unlocked" will provide patients with information about genetic testing and empower them to talk to their doctor about genetic testing and see...

The national media campaign aims to bring greater awareness of kidney disease within Black and Hispanic/Latino communities

Publication summarizes policy solutions arising from AKF's 2023 Patient Access Initiative Summit

A statement from LaVarne A. Burton, CEO and president of AKF, on the American Heart Association's advisory defining cardiovascular-kidney-metabolic syndrom...

AKF announces sponsorship from Novartis Pharmaceuticals Corporation for education and awareness campaigns for two rare kidney diseases: complement 3 glomerulopa...

AKF is excited to announce the formation of the UCKD Coalition, comprising 15 organizations and individuals aligned in their efforts to support policies and act...

Prevention and management campaign will feature new resources to help explain seriousness of kidney disease and how to help slow or stop its progression

AKF applauds the introduction of groundbreaking legislation that would have a positive impact on the millions of Americans who do not have an accurate diagnosis...

As a part of its Unknown Causes of Kidney Disease (UCKD) Project, AKF surveyed health care providers to understand opportunities and barriers in diagnosing chro...